Jana Illston
Urogynecology and Reconstructive Pelvic Surgery · Alpharetta, GANPI 1780904896
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,234 of the $3,778 with a category attached, or 85.6%. It is spread thinly across 33 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,352 and has fallen 86.2% since, to $186 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in GA, where the typical reported total is $3,861.
Across 144 payments — averaging $26.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$825
- Applied Medical Resources Corporation$538
- Astellas Pharma US Inc$517
- Caldera Medical, Inc$181
- AbbVie$168
- Aspira Women's Health Inc$157
- plus $1K from 27 others
What the payments were for
- Travel & lodging$3168%
- Food & beverage$3,23486%
- Education$2276%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 16 | $825 |
| Applied Medical Resources Corporation | 4 | $538 |
| Astellas Pharma US Inc | 21 | $517 |
| Caldera Medical, Inc | 4 | $181 |
| AbbVie(2 entities) | 9 | $168 |
| Aspira Women's Health Inc | 2 | $157 |
| Therapeuticsmd, Inc. | 21 | $152 |
| Pfizer | 9 | $142 |
| Hologic Sales And Service, LLC | 7 | $140 |
| Boston Scientific | 4 | $131 |
| Sumitomo Pharma America, Inc. | 4 | $99 |
| Bayer | 6 | $93 |
| Coopersurgical, Inc. | 4 | $92 |
| Mayne Pharma Commercial LLC | 6 | $63 |
| Organon | 4 | $58 |
| Millicent US Inc | 3 | $47 |
| Myovant Sciences Inc. | 2 | $40 |
| Axonics, Inc. | 2 | $35 |
| Urovant Sciences Inc | 1 | $35 |
| Lupin Inc. | 2 | $32 |
| Baxter Healthcare | 1 | $29 |
| Medtronic | 1 | $27 |
| Shield Therapeutics Inc | 1 | $25 |
| Scynexis, Inc. | 1 | $22 |
| Optumhealth Care Solutions, LLC | 1 | $20 |
| Roche Diagnostics Corporation | 1 | $18 |
| Laborie Medical Technologies Corp. | 1 | $17 |
| Merck | 1 | $14 |
| Novo Nordisk | 1 | $13 |
| Avanos Medical | 1 | $13 |
| Avion Pharmaceuticals | 1 | $12 |
| Vivus LLC | 1 | $11 |
| Meditrina | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$462
- GelPOINT V-Path$316
- Prolia$224
- Desara$101
How this compares
$3,778 in reported general payments places this provider in the 45th percentile of 32 urogynecology and reconstructive pelvic surgery providers in Georgia.
See all urogynecology and reconstructive pelvic surgery providers in Georgia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 39 | $35,876 |
| MyrbetriqMirabegron | 32 | $20,800 |
| Estradiol | 124 | $9,315 |
| Estradiol (Twice Weekly)Estradiol | 11 | $1,442 |
| ProgesteroneProgesterone, Micronized | 24 | $685 |
| Clobetasol Propionate | 12 | $297 |
| ValacyclovirValacyclovir Hcl | 12 | $220 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $99 | $35,87639 claims |
| Astellas Pharma US IncMyrbetriq | $517 | $20,80032 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 32 urogynecology and reconstructive pelvic surgery providers in Georgia.
Other urogynecology and reconstructive pelvic surgery in Alpharetta
- Peahen GandhiAlpharetta$2K
- Robert MooreAlpharetta$1K
- Jason BaileyGainesville$369K
- Cheau WilliamsMoultrie$192K
- David LovejoyMacon$85K
- Anne WiskindAtlanta$51K
- Barbara HenleyAugusta$37K
- Ivrose JosephAugusta$17K
- Jennifer LanzerGainesville$16K
- Joseph StubbsSavannah$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.